Search
X4 Pharmaceuticals Inc
XFORAdd to Watchlist
3.980USD
-0.020-0.50%
Close 07-31 16:00（ET）Quotes delayed by 15 min
375.39MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of X4 Pharmaceuticals Inc is 9.33, ranking 1 out of 155 in the Pharmaceuticals industry. The average price target is 7.50, with a high of 13.00 and a low of 4.00.
Analyst Rating
Based on
5
analysts
Strong Buy
Current Rating
11.600
Target Price
+191.46%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
X4 Pharmaceuticals Inc
XFOR
5
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
Pfizer Inc
PFE
32
AbbVie Inc
ABBV
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is X4 Pharmaceuticals Inc's expected revenue for the next quarter?
X4 Pharmaceuticals Inc's expected revenue is 2.42M.
What is X4 Pharmaceuticals Inc's price target?
Analysts forecast that X4 Pharmaceuticals Inc's price target is USD 7.50, with the highest forecast at USD 13.00 and the lowest forecast at USD 4.00.
How have X4 Pharmaceuticals IncXFOR's recent earnings per share performed?
The market expectation was USD -0.16, while X4 Pharmaceuticals IncXFOR's earnings per share (EPS) for the previous quarter was USD -0.26. EPS for the next quarter is expected at USD -0.18.
What is the analyst rating for X4 Pharmaceuticals Inc?
Based on the ratings of X4 Pharmaceuticals Inc's stock from 5 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.